Bill

Bill > S05284


NY S05284

Relates to cannabinoid hemp retail sales and retailers; makes technical changes to the definition of THC; provides specific requirements for labeling of cannabinoid hemp products.


summary

Introduced
02/20/2025
In Committee
02/20/2025
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the cannabis law, in relation to cannabinoid hemp retail sales and retailers

AI Summary

This bill makes several technical changes to New York's cannabis law regarding cannabinoid hemp retail sales and product regulations. The bill narrows the definition of THC to only include Delta-9-tetrahydrocannabinol, removing references to Delta-8 and Delta-10 tetrahydrocannabinol, and simplifies the calculation of "Total THC" to mean the dry weight percentage of Delta-9-THC in a product. The legislation introduces new labeling requirements for hemp-derived cannabinoid products, mandating that they include: a nutrition label with serving size, a warning that the product is not FDA-regulated and cannot treat medical conditions, the amount of hemp-derived product per serving in milligrams, and the manufacturer's or distributor's address. Additionally, the bill clarifies that cannabinoid hemp flower products (such as cigarettes, cigars, or pre-rolls) can only be sold to individuals 21 years of age and older, and allows the cannabis board to create regulations for processing, distribution, and sale of cannabinoid hemp products without infringing on licensed retailers' rights. The changes aim to provide more clarity and consumer protection in the cannabinoid hemp market.

Committee Categories

Government Affairs

Sponsors (1)

Last Action

REFERRED TO INVESTIGATIONS AND GOVERNMENT OPERATIONS (on 02/20/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...